Abstract
Experimental guinea pig asthma is a reliable and clinically relevant facsimile of human disease. The guinea pig is the preferred choice for use as a model of allergic bronchial asthma in the evaluation of anti-asthmatic drugs, since the airway anatomy and the response to inflammatory mediators is similar to humans. Further, the great strength of this model is the direct anaphylactic bronchoconstriction upon antigen challenge. Under certain conditions a late asthmatic response can be measured and airway hyperresponsiveness is observed in vitro and in vivo. Moreover, the inflammatory response is comparable with the human situation. More recent studies describe a chronic model for asthma in which airway remodeling is induced as can be observed in the asthmatic patients. The focus here is to demonstrate that guinea pig asthma models are useful for testing novel therapeutics.
Keywords: Allergy, asthma, guinea pig, early asthmatic reaction, late asthmatic reaction, airway hyperresponsiveness, airway inflammation, airway remodelling
Current Drug Targets
Title: The Guinea Pig as an Animal Model for Asthma
Volume: 9 Issue: 6
Author(s): Fabio L.M. Ricciardolo, Frans Nijkamp, Virginia De Rose and Gert Folkerts
Affiliation:
Keywords: Allergy, asthma, guinea pig, early asthmatic reaction, late asthmatic reaction, airway hyperresponsiveness, airway inflammation, airway remodelling
Abstract: Experimental guinea pig asthma is a reliable and clinically relevant facsimile of human disease. The guinea pig is the preferred choice for use as a model of allergic bronchial asthma in the evaluation of anti-asthmatic drugs, since the airway anatomy and the response to inflammatory mediators is similar to humans. Further, the great strength of this model is the direct anaphylactic bronchoconstriction upon antigen challenge. Under certain conditions a late asthmatic response can be measured and airway hyperresponsiveness is observed in vitro and in vivo. Moreover, the inflammatory response is comparable with the human situation. More recent studies describe a chronic model for asthma in which airway remodeling is induced as can be observed in the asthmatic patients. The focus here is to demonstrate that guinea pig asthma models are useful for testing novel therapeutics.
Export Options
About this article
Cite this article as:
Ricciardolo L.M. Fabio, Nijkamp Frans, Rose De Virginia and Folkerts Gert, The Guinea Pig as an Animal Model for Asthma, Current Drug Targets 2008; 9 (6) . https://dx.doi.org/10.2174/138945008784533534
DOI https://dx.doi.org/10.2174/138945008784533534 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Anti-Inflammatory Agents from Plants: Progress and Potential
Current Medicinal Chemistry The Emerging Role of Unmetabolized Folic Acid in Human Diseases: Myth or Reality?
Current Drug Metabolism Celastrol Inhibits Inflammatory Stimuli-Induced Neutrophil Extracellular Trap Formation
Current Molecular Medicine Analgesic and Anti-Inflammatory Effects of Essential Oils of Vitex agnuscastus L. from South-West of Algeria
Current Bioactive Compounds Mucoadhesive Chitosan Derivatives as Novel Drug Carriers
Current Pharmaceutical Design Structure, Function and Modulation of Chemokine Receptors: Members of the G-Protein-Coupled Receptor Superfamily
Mini-Reviews in Medicinal Chemistry Integrin Antagonists: A Special Emphasis on Structural Requirements of N-benzoyl-L-biphenylalanines as α4β7 and α4β1 Antagonists
Current Signal Transduction Therapy Current Paradigms in COVID-19 Research: Proposed Treatment Strategies, Recent Trends and Future Directions
Current Medicinal Chemistry Smoking and Obesity Increase Airway Hyperesponsiveness Risk in the Elderly
Current Aging Science Development and Production of Commercial Therapeutic Monoclonal Antibodies in Mammalian Cell Expression Systems: An Overview of the Current Upstream Technologies
Current Pharmaceutical Biotechnology Chitinases: Biomarkers for Human Diseases
Protein & Peptide Letters Pharmaceutical Treatment of Asthma in Children
Current Drug Targets - Inflammation & Allergy Poly(ADP-Ribose) Polymerases in Aging – Friend or Foe?
Current Protein & Peptide Science Current Therapeutic Options for the Treatment of Juvenile Idiopathic Arthritis
Current Rheumatology Reviews Microbial Biotransformation: Recent Developments on Steroid Drugs
Recent Patents on Biotechnology IgE-Mediated Disorders: Current Therapeutics and New Strategies Involving Synthetic Peptides
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Aspirin Intolerance: Experimental Models for Bed-to-Bench
Current Drug Targets Psychosocial Stress, Emotions and Cytokine-Related Disorders
Recent Patents on Inflammation & Allergy Drug Discovery Inflammation as a Therapeutic Target for Various Deadly Disorders: A Review
Current Drug Targets Interleukin-6 and Lung Inflammation: Evidence for a Causative Role in Inducing Respiratory System Resistance Increments
Inflammation & Allergy - Drug Targets (Discontinued)